Second Alzheimer’s drug in the pipeline promises to slow worsening but with safety concern ...Middle East

Sentinel-Tribune - News
Second Alzheimer’s drug in the pipeline promises to slow worsening but with safety concern
WASHINGTON (AP) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday. Eli Lilly and Co. is seeking Food and Drug Administration approval of donanemab. If cleared, it would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease — after the recently approved Leqembi from Japanese drugmaker Eisai. “Finally there’s some hope, right, that we can talk about,” Lilly’s Dr. John Sims told reporters Monday at the Alzheimer’s Association International Conference in Amsterdam. “We don’t cure the disease,” he said. “Diabetes doesn’t have a cure either — it doesn’t mean y

Hence then, the article about second alzheimer s drug in the pipeline promises to slow worsening but with safety concern was published today ( ) and is available on Sentinel-Tribune ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Second Alzheimer’s drug in the pipeline promises to slow worsening but with safety concern )

Apple Storegoogle play

Last updated :

Also on site :